Synthesis and Pharmacology of Halogenated δ-Opiod Selective [DAla2] Deltorphin II Peptide Analogs

Loading...
Thumbnail Image
Penn collection
BBB Major Publications
Degree type
Discipline
Subject
delta opiod receptor
deltorphin
radioiodination
sandmeyer
Chemicals and Drugs
Neurology
Neuroscience and Neurobiology
Neurosciences
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Pescatore, Robyn
Marrone, Gina F
Sedberry, Seth
Vinton, Daniel
Finkelstein, Netanel
Katlowitz, Yitzchak E
Pasternak, Gavril W
Wilson, Krista R
Majumdar, Susruta
Contributor
Abstract

Deltorphins are naturally occurring peptides produced by the skin of the giant monkey frog (Phyllomedusa bicolor). They are δ-opioid receptor-selective agonists. Herein, we report the design and synthesis of a peptide, Tyr-d-Ala-(pI)Phe-Glu-Ile-Ile-Gly-NH2 3 (GATE3-8), based on the [d-Ala2]deltorphin II template, which is δ-selective in in vitro radioligand binding assays over the μ- and κ-opioid receptors. It is a full agonist in [35S]GTPγS functional assays and analgesic when administered supraspinally to mice. Analgesia of 3 (GATE3-8) is blocked by the selective δ receptor antagonist naltrindole, indicating that the analgesic action of 3 is mediated by the δ-opioid receptor. We have established a radioligand in which 125I is incorporated into 3 (GATE3-8). The radioligand has a KD of 0.1 nM in Chinese hamster ovary (CHO) cells expressing the δ receptor. Additionally, a series of peptides based on 3 (GATE3-8) was synthesized by incorporating various halogens in the para position on the aromatic ring of Phe3. The peptides were characterized for binding affinity at the μ-, δ-, and κ-opioid receptors, which showed a linear correlation between binding affinity and the size of the halogen substituent. These peptides may be interesting tools for probing δ-opioid receptor pharmacology.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2015-04-01
Journal title
ACS Chemical Neuroscience
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
At the time of this publication, Dr. Katlowitz was affiliated with the Memorial Sloan-Kettering Cancer Center, but Dr. Katlowitz is now affiliated with the Children's Hospital of Philadelphia (CHOP).
Recommended citation
Collection